Scotia Capital »

Nervgen Pharma Ord shares owned by Scotia Capital

Quarter-by-quarter ownership of Nervgen Pharma Ord (NGENF) shares owned by Scotia Capital from 13F filings

Historical chart of Scotia Capital investment in Nervgen Pharma Ord

Tip: Access up to 7 years of quarterly data

All positions including Nervgen Pharma Ord held by Scotia Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nervgen Pharma Ord by Scotia Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $49k 13k 3.78

More positions owned by Scotia Capital

Rbc Cad (RY)
Toronto Dominion Bk Ont Com New (TD)
Bk Nova Cad (BNS)
Apple (AAPL)
Microsoft Corporation (MSFT)
Enbridge (ENB)
Amazon (AMZN)
Tc Energy Corp (TRP)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Fortis (FTS)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)
Bank Of Montreal Cadcom (BMO)
Canadian Natural Resources (CNQ)

View all positions for Scotia Capital

Top funds holding Nervgen Pharma Ord

PFG Investments
Bank of America Corporation
Royal Bank of Canada
Integrated Wealth Concepts
Valley Forge Investment Consultants Inc Adv
Bank Of Montreal
UBS Group
Patriot Financial Group Insurance Agency
Commonwealth Equity Services
Cetera Investment Advisers
McKinley Carter Wealth Services
Busey Trust Company
Sprott
TD Waterhouse Canada
Liberty Wealth Management

View all funds holding Nervgen Pharma Ord